GAUDIUM IVF AND WOMEN HEALTH LIMITED
₹ 75 - ₹ 79
20-Feb-2026 - 24-Feb-2026
₹ 14931.00

/ 189 Shares

GAUDIUM IVF AND WOMEN HEALTH LIMITED

20-Feb-2026 - 24-Feb-2026

₹ 75 - ₹ 79

Price Band

₹ 14931.00

Minimum Investment

189

Bid Lot

20,886,760

Shares

  • Face Value - ₹ 5/- Per Share

  • Listing at NSE BSE

  • 38,681 Application Required in Retail for 1 Time.

  • Registrar : Bigshare Services Pvt. Ltd

IPO Details

Fresh Issue of up to 1,13,92,500 Equity Shares and Offer For Sale of up to 94,93,700 Equity Shares

Category % Shares/Amount
QIB 50% 10,443,100 Shares RS.82.50 CR
HNI 1 5% 1,044,310 Shares RS.8.25 CR @ 395 FORM 1X
HNI 2 10% 2,088,620 Shares RS.16.50 CR @ 789 FORM 1X
Retail 35% 7,310,170 Shares RS.57.75 CR @ 38678 FORM 1X

BRLMs: Sarthi Capital Advisors Pvt. Ltd

Application Require for 1 Time

Retail (Upto 2 Lakh) HNI (2 Lakh to 10 Lakh) HNI (Above 10 Lakh)
38678 FORM 1X 395 FORM 1X 789 FORM 1X

IPO Lot Size

Category Lots Shares Amount
Retail (Upto 2 Lakh) 1 189 ₹ 14,931
Retail (Upto 2 Lakh) 13 2457 ₹ 194,103
S-HNI (2 Lakh to 10 Lakh) 14 2646 ₹ 209,034
S-HNI (2 Lakh to 10 Lakh) 66 12474 ₹ 985,446
B-HNI (Above 10 Lakh) 67 12663 ₹ 1,000,377

IPO Timeline

  • Open Date

    20-Feb-2026

  • Close Date

    24-Feb-2026

  • Basis of Allotment Date

    25-Feb-2026

  • Initiation of Refunds

    25-Feb-2026

  • Credit Shares to Demat A/c

    26-Feb-2026

  • IPO Listing Date

    27-Feb-2026

Subscription as on
24-Feb-2026 17:10

Category Book Size Subscription No. of Times
QIB 4,177,240 ₹ 33.00 Cr. 6,785,478 ₹ 53.61 Cr. 1.62x
HNI (<10 LAKH) 1,044,310 ₹ 8.25 Cr. 17,466,435 ₹ 137.98 Cr. 16.73x
HNI2 (>10 LAKH) 2,088,620 ₹ 16.50 Cr. 26,555,634 ₹ 209.79 Cr. 12.71x
RETAIL 7,310,730 ₹ 57.75 Cr. 55,542,942 ₹ 438.79 Cr. 7.60x
Total 14,620,900 106,350,489 7.27x
Category Book Size Subscription No. of Times
QIB 4,177,240 ₹ 33.00 Cr. 6,785,478 ₹ 53.61 Cr. 1.62x
HNI (<10 LAKH) 1,044,310 ₹ 8.25 Cr. 17,466,435 ₹ 137.98 Cr. 16.73x
HNI2 (>10 LAKH) 2,088,620 ₹ 16.50 Cr. 26,555,634 ₹ 209.79 Cr. 12.71x
RETAIL 7,310,730 ₹ 57.75 Cr. 55,542,942 ₹ 438.79 Cr. 7.60x
Total 14,620,900 106,350,489 7.27x

*Excluding Anchor

Total No. of Application Approx : ~242580 (6.27 Appwise)

Appwise Subscription
Category Total App App wise
HNIBT 6296.33 395 (For 1x) 15.94x
HNIAT 1983.60 789 (For 1x) 2.51x
RETAIL 226419.00 38678 (For 1x) 5.85x

Disclaimer: The above-mentioned information / data are sourced from the websites of National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) and are subject to change on real time basis. For updated information / data you can visit their respective website. The information / data provided herein above are for information purpose only and provided "AS IS" and "AS AVAILABLE" basis and without warranty, express or implied. We do not guarantee or warrant the accuracy, adequacy or completeness of the information received through the said websites. “We” hold not responsibility of any kind as regard to any discrepancies, errors, omissions, losses or damages. “We” including its affiliates and any of its officers, directors, personnel and employees, shall not liable for any loss, damage of any nature, including but not limited to direct, indirect, punitive, special, exemplary, consequential, as also any loss of profit in any way arising from the use of information / data received through the said websites. The recipient alone shall be fully responsible / are liable for any decision taken on the basis of such information / data. All recipients should before acting upon the said information make their own investigation, seek appropriate professional advice.

About Company

  • q The company was originally incorporated in the name of Gaudium IVF and Women Health Pvt. Ltd in 2015. Subsequently, on conversion to a public company in October 2024, the name was changed to Gaudium IVF and Women Health Limited. Dr Manika Khanna, Dr Peeyush Khanna, and Vishad Khanna are the promoters of the company.
  • q The company is engaged in IVF (in vitro fertilisation) treatment in India and has expanded to several states, using a hub-and-spoke model over the years.
  • q The company’s treatments include In Vitro Fertilization (IVF), Intracytoplasmic Sperm Injection (ICSI), Intrauterine Insemination (IUI) and ovulation induction. The treatment is carefully designed to address a variety of infertility challenges for both males and females.
  • q The company also offers laparoscopic and hysteroscopic surgeries for the diagnosis and treatment of infertility-related conditions, as well as genetic testing options, including Preimplantation Genetic Testing (PGT), designed to enhance pregnancy outcomes and mitigate the risks of genetic disorders.
  • q The company has a pan-India presence with 30+ locations, which comprises 7 hubs (centers) and 28 spokes. The company has entered into a strategic alliance with Spokes, i.e., Infertility Expert, to achieve the mutual goal of spreading awareness about ART and IVF treatments.
  • q  The Company’s main centers (Hubs) are in key cities across India, including 2 centers in Delhi, 1 in Maharashtra (Mumbai), 1 in Punjab (Ludhiana), 1 in Jammu & Kashmir (Srinagar), 1 in Bihar (Patna), and 1 in Karnataka (Bangalore). These hubs are strategically positioned to serve potential markets across the country.
  • q  The company has patients from countries such as Canada, the United Kingdom, the United States, Kenya, South Africa, and Oman.
  • q  The company has performed 3,512 cycles in FY 2023, 3,711 cycles in FY 2024, 3,476 cycles in FY 2025 and 1,824 cycles as of September 30, 2025. The total number of OPDs done during FY 2023, FY 2024, FY 2025 and during the period ended September 30, 2025, is 4,218, 7,208, 8,145 and 3,859, respectively.
Read More

Strengths

  • Patient Centric Approach
  • Expert Team
  • Modern Technology
  • Highly Technical USG Guided Services
  • Payment Options
  • Asset Light Business Model
  • Hubs in major Cities
  • Spokes Nearby Hubs

Company Promoters

Company Financials

Company Financials (Restated Consolidated)

Period Ended 30 Sep 2025 31 Mar 2025 31 Mar 2024 31 Mar 2023
Assets 106.62 88.51 51.01 36.63
Total Income 49.75 70.96 48.15 44.26
Profit After Tax 12.51 19.13 10.32 13.53
EBITDA 18.95 28.63 19.27 20.07
NET Worth 58.85 46.30 26.99 22.73
Reserves and Surplus 28.16 15.60 26.00 21.74
Total Borrowing 22.51 18.93 15.73 9.78
Amount in ? Crore

Objects of the Issue

# Issue Objects Est Amt (? Cr.)
1 Funding capital expenditure towards establishment of New IVF Centers of the Company. 50.00
2 Repayment/pre-payment, in full or in part, of certain outstanding loans availed by the Company. 20.00
3 General Corporate Purpose  
  Total 70.00

How to Apply

Apply for IPO in few simple steps.

  • Step 01 :

    Once you create your account, Login to InvestoYard.

  • Step 02 :

    Under IPO Section, you will be able to see a list of Ongoing IPOs, where you can click on apply button.

  • Step 03 :

    Add quantity of shares to apply – Maximum 3 bids are allowed (For retail category – max amount Rs.2,00,000/-).

  • Step 04 :

    Enter your UPI ID and you will receive mandate on your UPI App.

  • Step 05 :

    Once you accept the mandate, Application is submitted successful.

  • Applying for an IPO is easier than ever with InvestoYard, in just a few clicks your application is processed. You can bid for any IPO through InvestoYard, the bidding process is simple and hassle free. Every company has a lot size decided & you can buy in multiples of the decided lot.
  • If lot size is 15, then you have to bid for multiples of 15 share like 30,45,60 and so on.
  • The maximum subscription amount for retail investors is 2 lakh.
  • Any bid can be at a desired price or cut off price given by the company.

  • Enter the number of shares you wish to buy, as per the lot size.
  • You can apply at the cut off price set by the company or bid for a desired amount within the price band.
  • Maximum three bids will be accepted.
  • You then need to enter the UPI ID on InvestoYard’s IPO application form.

  • You will immediately get a fund blocked request on your UPI for the submitted IPO application.
  • The funds will be blocked in your bank account until allotment when it is debited.
  • The limit for IPO application is Rs 2 lakh per transaction on UPI.
  • On allotment of the shares, the money will be automatically debited.
  • If the share aren’t allotted the blocked funds will reflect back into your account.

Frequently Asked Questions

Check Allotment